Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease
ABSTRACT
Partners
-
-
- UNIVERSITAT ZURICH (Coordinator)
- UNIVERSIDAD DE MALAGA
- INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE (ITTM) SA
- LANDSPITALI UNIVERSITY HOSPITAL
- LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN
- THE UNIVERSITY OF NOTTINGHAM
- UNIVERSIDAD DE SALAMANCA
- FUNDACIO PRIVADA INSTITUT DE RECERCA DE L’HOSPITAL DE LA SANTA CREU I SANT PAU TAMIRNA GMBH
- SIGNATOPE GMBH
- ABX CRO ADVANCED PHARMACEUTICAL SERVICES FORSCHUNGSGESELLSCHAFT MBH
- METAHEPS GMBH
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
- SYNAPSE RESEARCH MANAGEMENT PARTNERS SL
-
-
-
- CHARITE – UNIVERSITAETSMEDIZIN BERLIN
- UNIVERSITY OF NEWCASTLE UPON TYNE
- THE UNIVERSITY OF LIVERPOOL
- MLM MEDICAL LABS GMBH
- UNIVERSITEIT LEIDEN
- SERVICIO ANDALUZ DE SALUD
- PFIZER LIMITED
- MERCK SHARP & DOHME CORP
- Eli Lilly and Company Limited
- NOVARTIS PHARMA AG
- HOFFMANN-LA ROCHE AG
- JANSSEN PHARMACEUTICA NV
- SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT
-